This firm currently holds 42.06
M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the entity is not taking enough advantage from borrowing. The company currently holds 42.06
M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the stock is not taking enough advantage from borrowing. Aphria Inc has a current ratio of 5.09, suggesting that it is liquid enough and is able to pay its financial obligations when due.
How important is Aphria's Liquidity
Aphria
financial leverage refers to using borrowed capital as a funding source to finance Aphria Inc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Aphria financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Aphria's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Aphria's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Aphria's total debt and its cash.
What is the case for Aphria Investors
The latest price spikes of Aphria Inc could raise concerns from investors as the firm closed today at a share price of
5.08 on
7,732,700 in volume. The company executives may have good odds in positioning the firm resources to exploit market volatility in
August. The stock standard deviation of daily returns for 30 days investing horizon is currently 5.55. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Aphria partners.
Asset Breakdown
| Total Assets | 2.26 Billion |
| Current Assets | 968.84 Million |
| Assets Non Current | 1.57 Billion |
| Goodwill | 992.84 Million |
| Tax Assets | 2.97 Million |
Will price continue to build-up in August 2020?
Aphria current coefficient of variation builds up over 856.01. Aphria Inc exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Aphria Inc individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Aphria future systematic risk.
The Bottom Line
Whereas some other firms within the drug manufacturers—specialty & generic industry are still a little expensive, even after the recent corrections, Aphria may offer a potential longer-term growth to investors. While some investors may not share our view we believe it may be a good time to quit Aphria as the risk-reward trade off is not appealing enough to hold a position. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Aphria.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Aphria Inc. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com